Enveric Biosciences, Inc. (ENVB)
1.42
+0.05
(+3.65%)
USD |
NASDAQ |
Sep 02, 16:00
1.42
0.00 (0.00%)
After-Hours: 16:51
Enveric Biosciences Cash from Operations (Annual) : -8.142M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -8.142M |
| December 31, 2024 | -7.726M |
| December 31, 2023 | -14.09M |
| December 31, 2022 | -17.15M |
| December 31, 2021 | -11.46M |
| December 31, 2020 | -3.889M |
| December 31, 2019 | -0.6479M |
| December 31, 2018 | -2.566M |
| December 31, 2017 | -2.741M |
| December 31, 2016 | -2.704M |
| December 31, 2015 | |
| December 31, 2014 | -0.0432M |
| December 31, 2013 | -0.0216M |
| December 31, 2012 | -0.0248M |
| Date | Value |
|---|---|
| December 31, 2011 | -0.0303M |
| December 31, 2010 | -0.0407M |
| December 31, 2009 | -0.065M |
| December 31, 2008 | -0.1502M |
| December 31, 2007 | 0.3299M |
| December 31, 2006 | -0.3059M |
| December 31, 2005 | -0.2566M |
| December 31, 2004 | 0.3439M |
| December 31, 2003 | -0.254M |
| December 31, 2002 | 0.0851M |
| December 31, 2001 | -0.3397M |
| December 31, 2000 | 0.1458M |
| December 31, 1999 | -0.6654M |
| December 31, 1998 | -2.997M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| LENZ Therapeutics, Inc. | -69.17M |
| Impact BioMedical, Inc. | -1.89M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |
| Veru, Inc. | -30.04M |